Approved and Non-FDA Approved COVID Treatments

February 11, 2022

Approved & Non-FDA Approved COVID Treatments

Approved treatments include:

  • remdesivir: cost $3,300.  FDA relied on ONE trial sponsored by the NIAID, headed by Fauci, which was NOT peer-reviewed, and which enrolled about 1,000 hospitalized COVID-positive patients, half of whom received the drug and the other half a placebo. Fauci announced that the drug “diminishes time to recovery” but doesn’t mention mortality, the true measuring stick. To date, Fauci has not made public his financial relations with the manufacturer, Gilead Sciences.
    • The treatment group had a median time to recovery of 10 days
    • placebo group had a time of 15 days
    • At 29 days, when monitoring concluded, the treatment group still had a somewhat higher recovery rate, but the difference was no longer statistically significant
    • Remdesivir has a frightening history and was pulled from a controlled trial for Ebola due to high death rates (53%).
    • Remdesivir is ineffective
    • Remdesivir is toxic and causes kidney poisoning, fluid in the lungs, organ damage, and death
    • Remdesivir received EUA designation in 2020 for COVID by the NIH panel, of which 9 had financial ties to Gilead Sciences – Remdesivir’s manufacturer.
    • Under EUA designation, a product can not be mandated by law.  Patients must provide consent including the facts:
      • they have a 99.7% chance of surviving COVID without it
      • their odds of dying increases exponentially if it is administered
      • odds of survival decrease exponentially when Remdesivir is combined with intubation  Source
  • Convalescent Plasma:  cost $5-10K. An unapproved treatment using antibodies from recovered patients.
    • In February, the FDA limited the treatments to hospitalized patients early in disease who had impaired humoral immunity 
    • In December the FDA revised the EUA again for only patients with immunosuppressive disease or who receive immunosuppressive treatments
  • Baricitinib:  cost $4,800.  An FDA approved arthritis drug which had results barely in the range of statistical significance. 
  • Monoclonal Antibody Therapy:  cost $1,000-2,000K.  While initial research showed it reduced mortality, a December study found it may no longer work on other variants.  Only one trial showed reduced hospitalization rates between 45-93% and it appears to still work against Omicron.
    • A RCT trial using bamlavivimab, a SARS-CoV-2 neutralizing monoclonal antibody in combination with remdesivir did not improve outcomes among hospitalized patients with COVID.
    • Sotrovimab, given EUA status, for mild-to-moderate COVID in adults and children (12 years of age and older weighing at least 88 pounds) has been found to cause drug-resistant mutations which patients can transmit to others. The FDA now is telling 8 states to stop using it.
  • Tocukuzynab:  cost $3,200.  Another FDA arthritis drug, EUA was based on four trials.
    • 3 smaller trials showed no statistically significant improvement in recovery time or mortality compared to placebo
    • one larger UK trial showed 31% mortality in the treatment group vs 35% in the “usual care” group – also near the edge of statistical significance.
  • Evusheld:  cost $10.  A non-approved monoclonal antibody treatment only used for prophylactic use in immunocompromised patients or those allergic to COVID shots. 
  • Paxlovid:  cost $530 for a treatment. Made by Pfizer, it received EUA in 2021 and is a combo of nirmatrelvir and ritonavir for “mild to moderate” COVID patients with high risk
  • The U.S. government has agreed to buy 10 million treatment courses.
    • It is not authorized for the pre-exposure or post-exposure prevention of COVID-19
    • It is not authorized in those requiring hospitalization due to severe or critical COVID-19.
    • Please see this important video that compares ivermectin to paxlovid.
  • Molnupiravir:  cost $700.  Made my Merck, it received EUA in 2021 and has been used heavily despite federal guidelines recommending Paxlovid due to accessibility.
    • It is not authorized for use in patients younger than 18 years of age because it may affect bone and cartilage growth.
    • It is not authorized for the pre-exposure or post-exposure prevention of COVID-19 or for initiation of treatment in patients hospitalized because benefit has not been observed in people when treatment started after hospitalization due to COVID-19.
    • data suggest it may cause birth defects
    • the largest trial showed mortality risk decreased between 14-99%
    • relative risk of hospitalization or death was decreased between 1-51%
    • this states it only showed 30% efficacy against hospitalization and death
    • it showed reduced efficacy against the Delta variant
    • researchers are concerned that due to the fact it induces mutations in a virus, which could lead to new, perhaps more dangerous variants
    • The U.S. government has agreed to buy 1.7 million rounds of treatment

But in a slick move, the FDA has removed COVID testing requirements to make it even easier to obtain Pfizer (Paxlovid) and Merck (Molnupiravir/Lagevrio) COVID treatments.   Now, exposed individuals with signs and symptoms (that look like any other flu-bug), can simply waltz into their doctor’s office and be diagnosed with COVID, even if they have a negative test result: however, they still can not obtain cheap, safe, effective drugs like ivermectin, HCQ, or even vitamin C.

Unauthorized Treatments include:

  • ivermectin: costs $45-95 for a treatment.
    • one of the most extensively studied drugs as a potential COVID therapeutic, there are more than 100 studies in 27 countries involving over 129,000 people  Source
    • most of the studies show positive effects, especially early on
    • when given early it blocks hemagglutination
    • it outperformed 9 other meds including Paxlovid for treating Omicron
    • a minority were small randomized, controlled, trials
    • the exception was in Singapore with over 3,000 low risk patients showing a 50% reduced risk of symptomatic infection when combined with HCQ, povidone-iodine, zinc, and vitamin C used as a prophyllactic
    • a meta-analysis of 19 RCTs indicated a risk of death reduction between 38-85%. 
    • A study in Brazil showed a 44% reduction in infection rates, 67% reduction in hospitalization rates, and 70% reduction in mortality.
    • doctors are suing the FDA for prohibiting ivermectin to treat COVID
    • courts are getting involved and to date all patients allowed to use it survive yet the Wisconsin Supreme Court has ruled that patients can’t force hospitals to administer it – even when they’ve tried everything else and the patients will die 
    • showing a very real medical cabal, the AMA and the WISMED filed an amicus brief against ivermectin
  • HCQ:  costs $7.  The first to receive EUA for hospitalized patients, the anti-viral was “too little, too late” in blocking the virus in the inflammatory phase, but few things work at that  stage
    • due to flawed research, HCQ and has showed mixed results
    • an in vitro study has shown it blocks viral entry 
    • a study found it caused 84% fewer hospitalizations 
    • a study found HCQ alone and in combination with azithromycin reduced COVID-related mortality
    • only a few dozen studies examined early treatment which have shown significant positive effects on mortality
    • 3 studies show HCQ reduces the chance of contracting COVID 
    • there has only been ONE early treatment RCT and results lacked statistical significance
    • when all prophylactic RCTs were combined in a meta-analysis, it showed risk of a positive case was cut by 28%.
    • doctor, after doctor, after doctor has used it successfully for COVID
  • Fluvoxamine:  costs $45. An antidepressant not studied as much as ivermectin and HCQ.
    • one RCT with about 1,500 people showed statistically significant reduction in hospitalization or extended emergency room by 30% 
  • Basic Compounds:  costs $3.50.
    • zinc
    • vitamin A
    • vitamin D
    • vitamin C
    • when RCTs are pooled with D & zinc, there is a statistically significant impact on mortality and other indicators
    • the question remains as to whether the compounds help in general or whether people are deficient to begin with
  • Others:  costs $10-230.  These are less researched but have shown positive results

Source

__________________

**Comment**

Please notice the price difference between approved and unapproved treatments. As they say, “follow the money,” and you will have your answer.

The issue of treatment is critical because if there are effective treatments, it makes the COVID shots null and void, which is why they are being heaviliy censored, denied, and banned. Hospitals and professional medical groups are completely in on the scam and are persecuting the doctors that are actively trying to help patients. It’s been a similar story in Lyme-land.

On a personal note, and again this is not a recommendation or treatment advice – I always defer you to your doctor for your own treatment, I’ve now personally seen miraculous results with ivermectin three times. I write about the first time here in the comment section. I used a combination of IV vitamin C, IV ozone, and ivermectin. The second time was in my husband.

The third time was just this past week after I developed what appeared to be a head cold that morphed into laryngitis, making it hard to speak. After fighting it for 5 days I could feel I was losing the battle and took ivermectin at night before bed. Dr. Kory’s group, FLCCC, has increased the dosage for acute, early cases:

  • 0.4–0.6 mg/kg per dose (take with or after a meal) — one dose daily, take for 5 days or until recovered. Use upper dose if: 1) in regions with aggressive variants (e.g. Delta); 2) treatment started on or after day 5 of symptoms or in pulmonary phase; or 3) multiple comorbidities/risk factors.
  • and/or Hydroxychloroquine (preferred for Omicron): 200 mg PO twice daily; take for 5 days or until recovered.

Since I’m taking it on or after day 5, I’m taking the upper dose of .6mg/kg, and since I responded so beautifully to it the first time, I’m omitting HCQ.

  • I routinely take zinc with selenium, vitamin C, D, a good multi, magnesium, fish oil, niacin, and other nutriceutricals and hormones, supplementing what my body lacks.  I’ve also starting sprouting seeds again and also making vegetable smoothies with limited fruit to up my vitamin and mineral uptake. 
  • This time, I also upped the strength of the nebulized hydrogen peroxide treatment by Dr. Levy to 3% and did it 3-4 times a day but was still losing the battle until the addition of ivermectin.  Please reacquaint yourself with Dr. Levy’s Rapid Virus Recovery document to read about the treatment:  RapidVirusRecovery  Levy states 3% is perfectly safe but will work more effectively due to the strength.  It did burn a little bit, but wasn’t a deal-killer.  If this bothers you, you can add a tad of saline solution as the salt water has a soothing effect.

I can tell you that similarly to the first time I took it, my body immediately responded to the ivermectin.  It completely dried me up (had leaking eyes and nose), and felt my immune system back on track fighting within hours of the first dose.  Speaking also became easier.  I expect nothing but further improvement, just like the last time.

I can definitely see why the ‘powers that be’ are coming against this effective treatment.  WHen I consider the thousands upon thousands that could be alive today had they had access to this, my blood boils.  Please share with others.  We need to get the word out.

Category:

Treatment, Viruses

Comments Off on Approved and Non-FDA Approved COVID Treatments

%d bloggers like this: